 |
인쇄하기
취소
|
GSK releases PritorPlus 80/25 mg
GlaxoSmithKline (GSK) said it has recently launched a new antihypertensive agent Pritor Plus 80/25 (telmisartan 80 mg/hydrochlorothiazide 25 mg).
The combination product is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on Pritor and/or Pritor plus hydrochlorothiazide (HCTZ) 12.5 mg.
"For physicians and patients, it is...
The combination product is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on Pritor and/or Pritor plus hydrochlorothiazide (HCTZ) 12.5 mg.
"For physicians and patients, it is...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.